Schematic overview of the 22q11.2 deletion region [2]
22q11.2 distal deletion syndrome is a rare genetic condition caused by a tiny missing part of one of the body's 46 chromosomes – chromosome 22. 22q11.2 distal deletion syndrome appears to be a recurrent genomic disorder distinct from 22q11.2 deletion syndrome also known as DiGeorge syndrome (DGS; 188400) and velocardiofacial syndrome (VCFS; 192430).[3]
The first published description of a person with a 22q11.2 distal deletion was in 1999.[4] There have since been hundreds of cases reported worldwide. 22q11.2 distal deletion syndrome seems to occur equally often in males and females. There are reports of people who are unaffected by carrying the deletion and only discovered it after their child was diagnosed. It seems that the 22q11.2 distal deletion can be "silent" and it is unknown how many people may have a silent form of this syndrome.
Presentation
Every 22q11.2 distal deletion is unique, and each person may have different medical and developmental concerns. A number of common features have emerged:[citation needed]
Some children are likely to need support with learning. The amount of support needed by each child will vary
Speech is often delayed and some children have articulation problems
Growth delay both in the womb and after birth
Heart problems
Behavioral difficulties such as difficulties with concentration and anxiety
Subtly unusual facial features. Families may notice similarities between their own child and others with the deletion
Cause
22q11.2 distal deletion occurs spontaneously; there is no known environmental cause. The genetic term for this is de novo; both parents typically have normal chromosomes. This is hereditary and people affected by distal deletion syndrome have a 50/50 chance of passing it to their children.[citation needed]
De novo 22q11.2 distal deletions are caused by a mistake that is thought to occur when the parents' sperm or egg cells are formed. At one point in the formation, all the chromosomes including the two chromosome 22s pair up and swap segments. To pair up precisely, each chromosome 'recognizes' matching or near-matching DNA sequences on its partner chromosome. However, throughout each chromosome there are many similar DNA sequences that can overlap incorrectly, and pair with the wrong sequence. It is believed that when the exchange of genetic material, known as 'crossing over', occurs after mismatching, it is unequal, looping out and excising a length of the chromosome.[citation needed]
Diagnosis
This section is empty. You can help by adding to it. (January 2018)
Treatment
This section is empty. You can help by adding to it. (January 2018)
Research
The features of 22q11.2 distal deletion syndrome are likely to be the result of the loss of a number of different genes found in this region. Most people have an approximately 0.4 to 2.1 Mb deletion (400'000- 2. Millions bases). Although the gene(s) responsible for the clinical features associated with 22q11.2 distal deletion syndrome have not been clearly defined, several potential candidate genes have been suggested.[citation needed]
CRKL and MAPK1 genes have been suggested to have a role in the heart anomalies that are common in 22q11.2 distal deletion syndrome. MAPK1 has also been suggested to be associated with placental development and therefore having one copy of this gene missing in 22q11.2 distal deletion syndrome may be linked to the tendency for premature birth and IUGR.[5] The MAPK1 gene in mice has been shown to contribute to social behavior[6] and therefore may play a role in the behavioral problems found in some people with 22q11.2 distal deletion syndrome.
Very distal deletions including the SMARCB1 gene are associated with an increased risk of malignant rhabdoid tumors. Very little is known about the magnitude of the risk for malignancy associated with distal 22q11.2 deletion syndrome but it is advised that people with a deletion that includes the SMARCB1 gene undergo careful, prolonged monitoring for this type of tumor. Most persons with 22q11 distal deletions do not have deletion of the SMARCB1 gene.[citation needed]
